PRINTING COMPONENTS LIMITED

Company number 06993745 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: PRINTING COMPONENTS LIMITED


1. Financial Health Score: C+

Explanation: The patient presents a deceptively robust exterior—strong net assets of nearly £900k and a long trading history since 2009—but is suffering from a serious underlying condition: rapidly deteriorating cash reserves and apparent recurring losses. The heavy reliance on inter-company balances (£702,364) as a proportion of current assets masks what would otherwise be a critically thin liquidity position. Like a patient with good muscle mass but poor circulation, this business has substance but is experiencing significant constraints on its financial oxygen supply.


2. Key Vital Signs

💓 Cash Position — CRITICAL

Year Cash Year-on-Year Change
2021 £505,771
2022 £131,780 -74%
2023 £232,718 +77%
2024 £99,729 -57%
2025 £56,183 -44%

Interpretation: This is the most alarming vital sign. Cash has plummeted by approximately 89% from its 2021 level. The most recent year saw cash nearly halve again. The cash-to-current-liabilities ratio stands at just 0.094—meaning the company has less than 10p for every £1 of short-term obligations. This is a patient struggling to breathe financially.

🩸 Working Capital — SUPERFICIALLY HEALTHY, INTERNALLY COMPROMISED

  • Net Current Assets: £717,919 (appears strong)
  • Current Ratio: 2.20 (appears healthy)
  • Quick Ratio: 2.10 (appears healthy)

However, £702,364 (53% of current assets) represents amounts owed by group undertakings. If we exclude these inter-company balances—which may not be readily convertible to cash—the adjusted figures become:

  • Adjusted Current Assets: £612,790
  • Adjusted Current Ratio: 1.03
  • Adjusted Net Current Assets: £15,555

This reveals the working capital is dangerously thin once the inter-company dependency is stripped away. Like relying on a family member to donate blood—it may work, but it's not a sustainable independent position.

🏥 Net Assets — STABLE BUT DECLINING

Year Net Assets Change
2022 £660,748
2023 £918,380 +39%
2024 £924,372 +0.7%
2025 £899,140 -2.7%

Net assets peaked in 2024 and have now declined. The P&L reserves dropped from £899,372 to £874,140—a reduction of £25,232, indicating the company made a loss in 2025.

📊 Liabilities — GROWING CONCERN

Liability Category 2024 2025 Change
Current Liabilities £554,876 £597,235 +7.6%
Long-term Liabilities £37,837 £99,499 +163%
Provisions £105,419 £93,252 -11.6%
Total £698,132 £789,986 +13.2%

Total liabilities have grown by 13.2% in a single year, with long-term creditors more than doubling. This represents a significant increase in the company's financial obligations.

🏭 Asset Composition — CAPITAL INTENSIVE WITH CONCENTRATION RISK

  • Fixed Assets: £373,972 (22% of total assets)
  • Intangible (development costs): £167,678
  • Tangible (plant, fixtures, vehicles): £206,294
  • Current Assets: £1,315,154 (78% of total assets)
  • Inter-company receivables: £702,364 (53% of current assets)
  • Trade debtors: £296,522
  • Other debtors: £164,301
  • Stock: £60,020
  • Cash: £56,183

The concentration in inter-company receivables is a structural vulnerability. If the group structure experiences distress, this company's liquidity would collapse rapidly.


3. Diagnosis

Primary Conditions

1. Acute Cash Flow Deficiency The company is experiencing a severe cash haemorrhage. With only £56,183 in cash against £597,235 in current liabilities, the business has approximately 34 days of cash coverage (assuming current liabilities are spread evenly across the year). This is dangerously low for a manufacturing business that needs working capital for raw materials, payroll (18 employees), and operations.

2. Inter-Company Dependency Syndrome Over half of current assets are amounts owed by group undertakings. While this may reflect normal group treasury arrangements, it creates a single point of failure. The company's apparent liquidity is largely an illusion created by intra-group lending rather than genuine third-party receivables.

3. Profitability Deterioration The reduction in P&L reserves of £25,232 indicates the company traded at a loss in 2025. This follows a period of growth in net assets (likely from retained profits in earlier years), suggesting the business cycle has turned negative.

4. Rising Leverage Long-term liabilities jumped from £37,837 to £99,499—a 163% increase. Combined with rising current liabilities, the company is taking on more debt while generating losses. This is a concerning trajectory.

5. Asset Quality Concerns Development costs (£167,678) represent intangible assets being amortised at 25% annually. The significant amortisation charge of £108,857 in the year suggests either substantial prior capitalisation or accelerated write-offs. The recoverability of these development costs depends entirely on future revenue generation—which, given current losses, is uncertain.

Secondary Observations

  • Trade Debtors of £296,522: Without turnover data, it's difficult to assess collection efficiency, but this represents a significant sum relative to cash balances.
  • Stock Levels: £60,020—relatively modest, which is appropriate for a component manufacturer but may indicate constraints on purchasing ability.
  • Hire Purchase Commitments: £47,982 in HP leases within current liabilities suggests ongoing asset financing requirements.
  • Corporation Tax: £68,652 owed—this is a positive sign as it indicates the company was profitable in a prior period, but it's also a cash outflow that will need to be funded.

4. Prognosis

Short-term Outlook (6-12 months): CAUTIOUS

The immediate concern is whether the company can meet its obligations as they fall due. With only £56,183 in cash and £597,235 in current liabilities, the business is heavily reliant on: - Collecting trade debts promptly - Inter-company settlements from group undertakings - Generating positive cash flow from operations

If any of these fail, the company could face a liquidity crisis.

Medium-term Outlook (1-3 years): GUARDED

The trajectory is concerning. The combination of: - Declining cash reserves - Rising liabilities - Apparent operating losses - Heavy inter-company dependence

...suggests the business is in a period of financial stress. However, the strong net asset base (£899,140) provides a buffer against insolvency, and the group structure may provide support through the inter-company arrangements.

Key Risk: Contagion from Group

As a subsidiary of PCL UK Holdings Limited (which owns >75% of shares), the company's fortunes are tied to the group. If the parent or fellow group companies experience distress, the £702,364 inter-company balance could become impaired, and the company's apparent working capital would evaporate.


5. Recommendations

🚨 Immediate Actions (0-3 months)

  1. Cash Flow Stabilisation: Implement a 13-week rolling cash flow forecast to identify and manage short-term liquidity gaps. This is the financial equivalent of putting the patient on a heart monitor.

  2. Inter-Company Balance Review: Negotiate clear repayment terms for the £702,364 owed by group undertakings. Establish whether this is a permanent feature of group treasury or a temporary balance that should be settling.

  3. Trade Debtor Collection: Focus management attention on collecting the £296,522 in trade debtors. Even a modest improvement in days sales outstanding could significantly improve cash position.

  4. Creditor Management: With £118,775 in trade creditors, ensure critical suppliers are paid on time to maintain supply relationships, while negotiating extended terms where possible.

💊 Medium-term Treatments (3-12 months)

  1. Profitability Recovery: Conduct a detailed review of the loss-making operations. The shift from profit to loss requires identification of the root causes—whether pricing pressure, cost inflation, or volume decline.

  2. Capital Expenditure Review: The company invested £111,500 in plant and equipment in 2025 while making a loss. Evaluate whether this investment is generating adequate returns and whether further capex should be deferred.

  3. Development Costs Assessment: With £167,678 in capitalised development costs and £108,857 in amortisation, review whether these intangible assets will generate future economic benefits. If not, an impairment charge may be necessary to present a true picture.

  4. Long-term Liability Management: The jump in long-term creditors from £37,837 to £99,499 needs investigation. Understand the terms, interest rates, and repayment schedules of these obligations.

🏋️ Long-term Health Improvements (12+ months)

  1. Diversify Revenue Streams: Reduce dependency on group arrangements by developing third-party revenue channels that generate independent cash flow.

  2. Working Capital Optimisation: Implement formal working capital management policies covering inventory, debtor days, and creditor terms.

  3. Financial Buffer Rebuilding: Target a minimum cash reserve equivalent to 3 months of operating costs to provide resilience against future shocks.


Risk Factors to Monitor

Indicator Current Status Warning Threshold Action Required
Cash Balance £56,183 Below £30,000 Immediate cash flow intervention
Current Ratio (excl. inter-company) 1.03 Below 1.0 Working capital injection
Inter-company Balance £702,364 Any increase Review group treasury policy
P&L Reserves Trend Declining Two consecutive loss years Strategic review
Long-term Liabilities £99,499 Any significant increase Debt serviceability assessment

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 18 August 2026